Page last updated: 2024-10-21

5,8,11-eicosatriynoic acid and Bone Loss, Osteoclastic

5,8,11-eicosatriynoic acid has been researched along with Bone Loss, Osteoclastic in 1 studies

5,8,11-eicosatriynoic acid: a lipoxygenase inhibitor
5,8,11-icosatriynoic acid : A C20 polyunsaturated fatty acid having three triple bonds in the 5-, 8- and 11-positions.

Research Excerpts

ExcerptRelevanceReference
"The effect of indomethacin on bone resorption was studied in an organ culture system, using calvarial bones from 6--7-day-old mice."1.26Indomethacin inhibits bone resorption and lysosomal enzyme release from bone in organ culture. ( Lerner, U, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lerner, U1

Other Studies

1 other study available for 5,8,11-eicosatriynoic acid and Bone Loss, Osteoclastic

ArticleYear
Indomethacin inhibits bone resorption and lysosomal enzyme release from bone in organ culture.
    Scandinavian journal of rheumatology, 1980, Volume: 9, Issue:3

    Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Eicosanoic Acids; Fatty Acids, Unsaturated; Gluco

1980